DK

Daniel Johannes KOWALEWSKI

IG Immatics Biotechnologies Gmbh: 62 patents #5 of 48Top 15%
📍 Rötteln, DE: #4 of 26 inventorsTop 20%
Overall (2021): #176 of 548,734Top 1%
62
Patents 2021

Issued Patents 2021

Showing 26–50 of 62 patents

Patent #TitleCo-InventorsDate
11020433 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk +1 more 2021-06-01
11020434 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk +1 more 2021-06-01
11020432 Peptides and combination thereof for use in the immunotherapy against cancers Juliane Walz, Markus LOEFFLER, Moreno DI MARCO, Nico TRAUTWEIN, Annika NELDE +3 more 2021-06-01
11013768 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk +1 more 2021-05-25
11013766 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk +1 more 2021-05-25
11013769 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk +1 more 2021-05-25
11014972 B*44 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Heiko SCHUSTER, Oliver Schoor, Jens Fritsche, Toni Weinschenk +1 more 2021-05-25
11007223 Peptides and combination thereof for use in the immunotherapy against cancers Juliane Walz, Markus LOEFFLER, Moreno DI MARCO, Nico TRAUTWEIN, Annika NELDE +3 more 2021-05-18
11001617 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Heiko SCHUSTER, Annika Sonntag, Oliver Schoor, Jens Fritsche, Toni Weinschenk +2 more 2021-05-11
10993964 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk +1 more 2021-05-04
10993963 Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers Juliane Walz, Markus LOEFFLER, Moreno DI MARCO, Nico TRAUTWEIN, Annika NELDE +3 more 2021-05-04
10993962 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk +1 more 2021-05-04
10954281 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Heiko SCHUSTER, Annika Sonntag, Oliver Schoor, Jens Fritsche, Toni Weinschenk +2 more 2021-03-23
10946081 *03 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Linus Backert, Heiko SCHUSTER, Oliver Schoor, Jens Fritsche +2 more 2021-03-16
10925947 A*03 restricted peptides for use in immunotherapy against cancers and related methods Colette Song, Linus Backert, Heiko SCHUSTER, Oliver Schoor, Jens Fritsche +2 more 2021-02-23
10925949 Immunotherapy against several tumors of the blood, such as acute myeloid leukemia (AML) Hans-Georg Rammensee, Stefan Stevanovic, Juliane Walz, Claudia Berlin 2021-02-23
10919933 Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers Hans-Georg Rammensee, Juliane Walz, Stefan Stevanovic, Simon Walz 2021-02-16
10905720 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk +1 more 2021-02-02
10906938 Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers Hans-Georg Rammensee, Juliane Walz, Stefan Stevanovic, Simon Walz 2021-02-02
10905719 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk +1 more 2021-02-02
10898518 Peptides and combination of peptides of non-canonical origin for use in immunotherapy against different types of cancers Heiko SCHUSTER, Franziska Hoffgaard, Jens Fritsche, Oliver Schoor, Toni Weinschenk +1 more 2021-01-26
10899819 Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers Juliane Walz, Markus Loffler, Moreno DI MARCO, Nico TRAUTWEIN, Annika NELDE +3 more 2021-01-26
10899814 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Heiko SCHUSTER, Annika Sonntag, Oliver Schoor, Jens Fritsche, Toni Weinschenk +2 more 2021-01-26
10899813 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Heiko SCHUSTER, Annika Sonntag, Oliver Schoor, Jens Fritsche, Toni Weinschenk +2 more 2021-01-26
10899812 Immunotherapy with A*01 restricted peptides and combination of peptides against cancers and related methods Heiko SCHUSTER, Annika Sonntag, Oliver Schoor, Jens Fritsche, Toni Weinschenk +2 more 2021-01-26